Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson’s disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
2016 ◽
Vol 29
◽
pp. 17-23
◽
2015 ◽
Vol 16
(7)
◽
pp. 961-970
◽
2019 ◽
Vol 08
(02)
◽
pp. 18-34
◽
2010 ◽
Vol 9
(6)
◽
pp. 581-591
◽
Keyword(s):
2018 ◽
Vol 11
◽
pp. 175628641875931
◽
2001 ◽
Vol 24
(6)
◽
pp. 346-351
◽
2015 ◽
Vol 31
(4)
◽
pp. 723-730
◽